Kayla Barnes-Lentz is redefining the future of longevity by putting women at the center of it.
A leading voice in female-specific health optimisation, Bernes-Lentz is widely known as one of the world’s foremost longevity experts and the most publicly measured woman in the field. For over a decade, she has worked to close the gender gap in longevity science and build a new, data-driven model designed specifically for women’s biology.
Her work challenges a fundamental flaw in modern medicine. While women live longer than men, they spend more of those years in poor health. Largely because the science of aging has historically been built on male data but Kayla Barnes-Lentz is changing that narrative. Through rigorous biomarker tracking and radical transparency, she has created one of the most comprehensive real-world case studies in female longevity ever documented. She publicly shares everything from her ovarian biological age and hormonal cycles to metabolic health, mitochondrial function, and performance metrics.
But her work goes far beyond personal experimentation. Barnes-Lentz translates complex, often fragmented science into a structured, evidence-based framework for extending women’s healthspan. It accounts for hormonal rhythms, reproductive transitions, metabolic shifts, and the nuanced realities of female physiology. Her research spans ovarian aging, muscle preservation, bone density, circadian biology, inflammation, and environmental health. It also reframes longevity not as “anti-aging,” but as precise, measurable biological optimisation.
As co-founder of one of the most innovative longevity clinics in the United States, Barnes-Lentz has helped bring cutting-edge, preventative and regenerative health strategies into practice. She is also the host of the Longevity Optimization Podcast, where she interviews leading scientists, physicians, and thinkers, translating frontier research into actionable insights for a global audience.
A sought-after international speaker, Kayla Barnes-Lentz has shared her work on stages around the world, sparking critical conversations about the future of health, aging, and the urgent need for sex-specific research.
